CD44 and osteoarthritis: Previous studies have reported that combination therapy with PRP and HA can further modify the inflammatory cytokines of the degenerative progression of chondrocytes, via certain mediators (CD44 and transforming growth factor β type II receptor), and correspondingly improve the regeneration of cartilage and decrease the inflammation in osteoarthritis [14,19].